3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 3
2
Phase NA
1
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Osteoporosis
2
Breast Neoplasms
2
Bone Diseases, Metabolic
2
Prostatic Neoplasms
1
Interventions
Risedronic Acid
2
Zoledronic Acid
1
Kyphoplasty
1
Cholecalciferol
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Bone Diseases, Metabolic
×
Risedronic Acid
×
Clear all
NCT00485953
2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4
Completed
109 enrolled
11 charts
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled